Heather Feigelson to Anthracyclines
This is a "connection" page, showing publications Heather Feigelson has written about Anthracyclines.
Connection Strength
0.353
-
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. J Natl Cancer Inst. 2024 Aug 01; 116(8):1384-1394.
Score: 0.246
-
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
Score: 0.108